These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 10595936)
1. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast. Gugger M; Reubi JC Am J Pathol; 1999 Dec; 155(6):2067-76. PubMed ID: 10595936 [TBL] [Abstract][Full Text] [Related]
2. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Markwalder R; Reubi JC Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977 [TBL] [Abstract][Full Text] [Related]
3. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting. Reubi C; Gugger M; Waser B Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125 [TBL] [Abstract][Full Text] [Related]
4. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14). Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125 [TBL] [Abstract][Full Text] [Related]
5. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications. Fleischmann A; Waser B; Reubi JC Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282 [TBL] [Abstract][Full Text] [Related]
6. In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues. Thomas R; Chen J; Roudier MM; Vessella RL; Lantry LE; Nunn AD Clin Exp Metastasis; 2009; 26(2):105-19. PubMed ID: 18975117 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms. Fleischmann A; Waser B; Reubi JC Cell Oncol; 2007; 29(5):421-33. PubMed ID: 17726264 [TBL] [Abstract][Full Text] [Related]
8. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer. Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989 [TBL] [Abstract][Full Text] [Related]
10. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Halmos G; Wittliff JL; Schally AV Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958 [TBL] [Abstract][Full Text] [Related]
11. Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. Fleischmann A; Waser B; Gebbers JO; Reubi JC J Clin Endocrinol Metab; 2005 Aug; 90(8):4722-9. PubMed ID: 15941862 [TBL] [Abstract][Full Text] [Related]
13. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases. Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096 [TBL] [Abstract][Full Text] [Related]
14. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA. Waser B; Eltschinger V; Linder K; Nunn A; Reubi JC Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):95-100. PubMed ID: 16909223 [TBL] [Abstract][Full Text] [Related]
15. Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma. Pansky A; DE Weerth A; Fasler-Kan E; Boulay JL; Schulz M; Ketterer S; Selck C; Beglinger C; VON Schrenck T; Hildebrand P J Am Soc Nephrol; 2000 Aug; 11(8):1409-1418. PubMed ID: 10906154 [TBL] [Abstract][Full Text] [Related]
16. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature. Reubi JC; Fleischmann A; Waser B; Rehmann R Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085 [TBL] [Abstract][Full Text] [Related]
18. Bombesin receptor antagonists may be preferable to agonists for tumor targeting. Cescato R; Maina T; Nock B; Nikolopoulou A; Charalambidis D; Piccand V; Reubi JC J Nucl Med; 2008 Feb; 49(2):318-26. PubMed ID: 18199616 [TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of avian bombesin-like peptide receptors: new tools for investigating molecular basis for ligand selectivity. Iwabuchi M; Ui-Tei K; Yamada K; Matsuda Y; Sakai Y; Tanaka K; Ohki-Hamazaki H Br J Pharmacol; 2003 Jun; 139(3):555-66. PubMed ID: 12788815 [TBL] [Abstract][Full Text] [Related]
20. Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging? Van de Wiele C; Dumont F; van Belle S; Slegers G; Peers SH; Dierckx RA Nucl Med Commun; 2001 Jan; 22(1):5-15. PubMed ID: 11233552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]